脊椎生物製剤市場：製品、用途、エンドユーザー別-2025～2030年の世界予測

脊椎生物製剤市場の2023年の市場規模は30億米ドルで、2024年には31億5,000万米ドルに達すると予測され、CAGR 5.24％で成長し、2030年には43億米ドルに達すると予測されています。

脊椎生物製剤市場は、医療用生体材料と生物学的療法という広範なセグメントの中でも、主に脊椎の治癒と再生を促進する製品に焦点を当てた専門セグメントです。これには通常、脊椎固定術に使用される骨移植代替物、成長因子、細胞ベースのマトリックスが含まれます。脊椎生物製剤の必要性は、変性椎間板症、脊柱管狭窄症、外傷性脊椎損傷などの脊椎疾患の有病率の増加から生じており、これらの疾患は人口の高齢化や座りがちなライフスタイルによって悪化することが多いです。脊椎固定術は、骨の成長を促進することで脊柱を安定させ、慢性的な背中の痛みや不安定性を緩和することを目的としています。最終用途セグメントには、病院、専門クリニック、外来手術センターが含まれ、患者の回復を早め手術リスクを軽減する低侵襲手術への動向が高まっています。

市場に影響を与える主要成長要因としては、生物製剤の技術的進歩、低侵襲手術に対する患者の嗜好の高まり、再生療法における広範な研究開発活動などが挙げられます。最新のビジネス機会は、医療インフラが拡大し、先進治療に対する認識が高まっている新興市場にあります。さらに、バイオテクノロジー企業と病院とのパートナーシップは、革新的な脊椎生物製剤ソリューションの採用を促進する役割を果たす可能性があります。しかし、市場開拓は、開発コストの高さ、規制当局の承認の厳しさ、特定の地域における償還の課題によって制約を受け、製品入手の妨げとなっています。

技術革新の可能性があるセグメントとしては、より優れた統合性と治癒時間を提供する新しい生物学的材料の開発、カスタマイズ可能な治療法を生み出すための遺伝子治療と組織工学の探求などが挙げられます。個別化医療アプローチの調査も競争優位性をもたらす可能性があります。市場は急速な技術進歩に伴い比較的ダイナミックであるため、進化する臨床需要や規制状況を先取りすることが極めて重要です。技術革新と手頃な価格や規制遵守のバランスを効果的にとることができる企業は、脊椎生物製剤のセグメントで持続的な成長を遂げ、市場への浸透を高めることができると考えられます。

市場力学：急速に進化する脊椎生物製剤市場における重要な市場洞察の解明

脊椎生物製剤市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネス機会の獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 低侵襲手術に対する需要と嗜好の高まり
  • 変性脊椎疾患の罹患率の上昇と治療率の上昇
  • 骨移植手技の進歩の急増
• 市場抑制要因
  • 治療費の高騰
• 市場機会
  • 脊椎疾患の治療を改善する生体材料の継続的な進歩
  • 調査拡大のための政府資金援助
• 市場課題
  • 製品リコールに関する問題

ポーターのファイブフォース：脊椎生物製剤市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、脊椎生物製剤市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：脊椎生物製剤市場における外部からの影響の把握

外部マクロ環境要因は、脊椎生物製剤市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：脊椎生物製剤市場における競合情勢の把握

脊椎生物製剤市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：脊椎生物製剤市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、脊椎生物製剤市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：脊椎生物製剤市場における成功への道筋を描く

脊椎生物製剤市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 低侵襲手術に対する需要と好みの高まり
    • 変性脊椎疾患の発生率と治療率の上昇
    • 骨移植手術の進歩の急増
  • 抑制要因
    • 治療費が高い
  • 機会
    • 脊椎疾患の治療を改善する生体材料の継続的な進歩
    • 政府資金による脊椎生物製剤調査の拡大
  • 課題
    • 製品リコールに関する問題
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 脊椎生物製剤市場：製品別

• イントロダクション
• 骨移植代替品
  • 骨形成タンパク質
  • 人工骨移植
• セルベースマトリックス
• 脊椎同種移植
  • 脱灰骨マトリックス
  • 機械加工骨同種移植

第7章 脊椎生物製剤市場：用途別

• イントロダクション
• 非融合
• 脊椎固定術

第8章 脊椎生物製剤市場：エンドユーザー別

• イントロダクション
• 外来手術センター
• 病院

第9章 南北アメリカの脊椎生物製剤市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋の脊椎生物製剤市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの脊椎生物製剤市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • Bone Biologics、オーストラリアの脊椎固定術患者を対象にNB1のパイロット臨床検査を開始するためのヒト研究倫理委員会の承認を取得
  • PUR Biologics、脊椎手術用の生体活性成形可能合成材料PURcoreの発売を発表
  • Induce Biologics、NMPキャンセラスストリップの発売を発表
• 戦略分析と提言

企業一覧

• Alphatec Spine, Inc.
• Arthrex Inc.
• Aziyo Biologics
• Baxter International Inc.
• Biomatlante SAS
• Bone Biologics Corp.
• Camber Spine Technologies, LLC
• Cerapedics, Inc
• ChoiceSpine LLC
• CoreLink, LLC by ZAVATION
• Globus Medical, Inc.
• Induce Biologics USA Inc.
• Innovasis, Inc.
• Integra LifeSciences Corporation
• InVivo Therapeutics Corp.
• Johnson & Johnson Services, Inc.
• Kuros Biosciences A.G.
• Life Spine, Inc.
• LifeNet Health
• Medtronic PLC
• MTF Biologics
• ORHub Inc
• Orthofix Medical Inc.
• RTI Surgical, Inc.
• Smith & Nephew PLC
• Spinal Elements, Inc.
• Stryker Corporation
• Tyber Medical LLC
• Xtant Medical Holdings, Inc.
• Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

• FIGURE 1. SPINE BIOLOGICS MARKET RESEARCH PROCESS
• FIGURE 2. SPINE BIOLOGICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL SPINE BIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. SPINE BIOLOGICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. SPINE BIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. SPINE BIOLOGICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL SPINE BIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. SPINE BIOLOGICS MARKET DYNAMICS
• TABLE 7. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEINS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY CELL-BASE MATRIX, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY MACHINED BONES ALLOGRAFT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY NON-FUSION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. CANADA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. CANADA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 41. CANADA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 42. CANADA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. CANADA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 61. AUSTRALIA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. AUSTRALIA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 63. AUSTRALIA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. CHINA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. CHINA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 68. CHINA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 69. CHINA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. CHINA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. INDIA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. INDIA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 73. INDIA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 74. INDIA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. INDIA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. INDONESIA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. INDONESIA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 78. INDONESIA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. JAPAN SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. JAPAN SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 83. JAPAN SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. MALAYSIA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. MALAYSIA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 88. MALAYSIA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. PHILIPPINES SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. PHILIPPINES SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 93. PHILIPPINES SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. SINGAPORE SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. SINGAPORE SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 98. SINGAPORE SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. SOUTH KOREA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. SOUTH KOREA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 103. SOUTH KOREA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. TAIWAN SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. TAIWAN SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 108. TAIWAN SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. THAILAND SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. THAILAND SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 113. THAILAND SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. VIETNAM SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. VIETNAM SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 118. VIETNAM SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 123. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 127. DENMARK SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. DENMARK SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 129. DENMARK SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. EGYPT SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 133. EGYPT SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 134. EGYPT SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. FINLAND SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. FINLAND SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 139. FINLAND SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. FRANCE SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. FRANCE SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 144. FRANCE SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. GERMANY SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 148. GERMANY SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 149. GERMANY SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 152. ISRAEL SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 153. ISRAEL SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 154. ISRAEL SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 157. ITALY SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 158. ITALY SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 159. ITALY SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 160. ITALY SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 161. ITALY SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 162. NETHERLANDS SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 163. NETHERLANDS SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 164. NETHERLANDS SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 167. NIGERIA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 168. NIGERIA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 169. NIGERIA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 172. NORWAY SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 173. NORWAY SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 174. NORWAY SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 177. POLAND SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 178. POLAND SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 179. POLAND SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 180. POLAND SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 181. POLAND SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 182. QATAR SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 183. QATAR SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 184. QATAR SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 185. QATAR SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 186. QATAR SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 187. RUSSIA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 188. RUSSIA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 189. RUSSIA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 192. SAUDI ARABIA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 193. SAUDI ARABIA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 194. SAUDI ARABIA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 197. SOUTH AFRICA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 198. SOUTH AFRICA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 199. SOUTH AFRICA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 202. SPAIN SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 203. SPAIN SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 204. SPAIN SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 207. SWEDEN SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 208. SWEDEN SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 209. SWEDEN SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 212. SWITZERLAND SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 213. SWITZERLAND SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 214. SWITZERLAND SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 217. TURKEY SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 218. TURKEY SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 219. TURKEY SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 222. UNITED ARAB EMIRATES SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 223. UNITED ARAB EMIRATES SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 224. UNITED ARAB EMIRATES SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 227. UNITED KINGDOM SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 228. UNITED KINGDOM SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 229. UNITED KINGDOM SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 232. SPINE BIOLOGICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 233. SPINE BIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2023

The Spine Biologics Market was valued at USD 3.00 billion in 2023, expected to reach USD 3.15 billion in 2024, and is projected to grow at a CAGR of 5.24%, to USD 4.30 billion by 2030.

The spine biologics market is a specialized sector within the broader field of medical biomaterials and biological therapies, primarily focused on products that promote spinal healing and regeneration. This typically includes bone graft substitutes, growth factors, and cell-based matrices used in spinal fusion procedures. The necessity of spine biologics arises from the increasing prevalence of spinal disorders such as degenerative disc disease, spinal stenosis, and traumatic spinal injuries, which are often exacerbated by aging populations and sedentary lifestyles. Applications extend predominantly to spinal fusion surgeries, which aim to alleviate chronic back pain and instability by enhancing bone growth and thus stabilizing the spinal column. End-use segments include hospitals, specialty clinics, and ambulatory surgical centers, with an increasing trend toward minimally invasive procedures that accelerate patient recovery and reduce surgical risks.

Key growth factors influencing the market include technological advancements in biologics, increasing patient preference for minimally invasive surgeries, and extensive R&D activities in regenerative therapies. The latest opportunities lie in emerging markets with expanding healthcare infrastructures and increasing awareness of advanced treatments. Furthermore, partnerships between biotech firms and hospitals could serve to expedite the adoption of innovative spine biologics solutions. However, market growth is constrained by high costs of development, stringent regulatory approvals, and reimbursement challenges in certain regions, which can hinder product accessibility.

Potential areas for innovation include the development of new biologic materials that offer better integration and healing time, and the exploration of gene therapy and tissue engineering to create customizable therapies. Research into personalized medicine approaches can also provide a competitive edge. As the market is relatively dynamic with rapid technological progress, it is crucial to stay ahead of evolving clinical demands and regulatory landscapes. Firms that can effectively balance innovation with affordability and regulatory compliance are likely to see sustained growth and increased market penetration in the spine biologics arena.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Spine Biologics Market

The Spine Biologics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing demand and preference for minimally invasive procedures
  • Rising incidence of degenerative spine disorders and rise in treatment rates
  • Proliferation in advancements of bone grafting procedures
• Market Restraints
  • High cost of treatment
• Market Opportunities
  • Ongoing advancements in biomaterials improving the treatment of spine disorders
  • Government funding to expand spine biologics research
• Market Challenges
  • Issues related to product recalls

Porter's Five Forces: A Strategic Tool for Navigating the Spine Biologics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Spine Biologics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Spine Biologics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Spine Biologics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Spine Biologics Market

A detailed market share analysis in the Spine Biologics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Spine Biologics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Spine Biologics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Spine Biologics Market

A strategic analysis of the Spine Biologics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Spine Biologics Market, highlighting leading vendors and their innovative profiles. These include Alphatec Spine, Inc., Arthrex Inc., Aziyo Biologics, Baxter International Inc., Biomatlante SAS, Bone Biologics Corp., Camber Spine Technologies, LLC, Cerapedics, Inc, ChoiceSpine LLC, CoreLink, LLC by ZAVATION, Globus Medical, Inc., Induce Biologics USA Inc., Innovasis, Inc., Integra LifeSciences Corporation, InVivo Therapeutics Corp., Johnson & Johnson Services, Inc., Kuros Biosciences A.G., Life Spine, Inc., LifeNet Health, Medtronic PLC, MTF Biologics, ORHub Inc, Orthofix Medical Inc., RTI Surgical, Inc., Smith & Nephew PLC, Spinal Elements, Inc., Stryker Corporation, Tyber Medical LLC, Xtant Medical Holdings, Inc., and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Spine Biologics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Bone Graft Substitutes, Cell-Base Matrix, and Spinal Allografts. The Bone Graft Substitutes is further studied across Bone Morphogenetic Proteins and Synthetic Bone Grafts. The Spinal Allografts is further studied across Demineralized Bone Matrix and Machined Bones Allograft.
• Based on Application, market is studied across Non-Fusion and Spinal Fusion.
• Based on End-user, market is studied across Ambulatory Surgical Centers and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing demand and preference for minimally invasive procedures
    • 5.1.1.2. Rising incidence of degenerative spine disorders and rise in treatment rates
    • 5.1.1.3. Proliferation in advancements of bone grafting procedures
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of treatment
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing advancements in biomaterials improving the treatment of spine disorders
    • 5.1.3.2. Government funding to expand spine biologics research
  • 5.1.4. Challenges
    • 5.1.4.1. Issues related to product recalls
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Spine Biologics Market, by Product

• 6.1. Introduction
• 6.2. Bone Graft Substitutes
  • 6.2.1. Bone Morphogenetic Proteins
  • 6.2.2. Synthetic Bone Grafts
• 6.3. Cell-Base Matrix
• 6.4. Spinal Allografts
  • 6.4.1. Demineralized Bone Matrix
  • 6.4.2. Machined Bones Allograft

7. Spine Biologics Market, by Application

• 7.1. Introduction
• 7.2. Non-Fusion
• 7.3. Spinal Fusion

8. Spine Biologics Market, by End-user

• 8.1. Introduction
• 8.2. Ambulatory Surgical Centers
• 8.3. Hospitals

9. Americas Spine Biologics Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Spine Biologics Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Spine Biologics Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Bone Biologics Receives Human Research Ethics Committee Approval to Begin Pilot Clinical Trial with NB1 in Spinal Fusion Patients in Australia
  • 12.3.2. PUR Biologics Announces Launch of PURcore, a bioActive Moldable Synthetic for Spine Surgery
  • 12.3.3. Induce Biologics Announces Launch of NMP Cancellous Strips
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Alphatec Spine, Inc.
• 2. Arthrex Inc.
• 3. Aziyo Biologics
• 4. Baxter International Inc.
• 5. Biomatlante SAS
• 6. Bone Biologics Corp.
• 7. Camber Spine Technologies, LLC
• 8. Cerapedics, Inc
• 9. ChoiceSpine LLC
• 10. CoreLink, LLC by ZAVATION
• 11. Globus Medical, Inc.
• 12. Induce Biologics USA Inc.
• 13. Innovasis, Inc.
• 14. Integra LifeSciences Corporation
• 15. InVivo Therapeutics Corp.
• 16. Johnson & Johnson Services, Inc.
• 17. Kuros Biosciences A.G.
• 18. Life Spine, Inc.
• 19. LifeNet Health
• 20. Medtronic PLC
• 21. MTF Biologics
• 22. ORHub Inc
• 23. Orthofix Medical Inc.
• 24. RTI Surgical, Inc.
• 25. Smith & Nephew PLC
• 26. Spinal Elements, Inc.
• 27. Stryker Corporation
• 28. Tyber Medical LLC
• 29. Xtant Medical Holdings, Inc.
• 30. Zimmer Biomet Holdings, Inc.